GB0511019D0 - Drug fusions and conjugates - Google Patents

Drug fusions and conjugates

Info

Publication number
GB0511019D0
GB0511019D0 GB0511019A GB0511019A GB0511019D0 GB 0511019 D0 GB0511019 D0 GB 0511019D0 GB 0511019 A GB0511019 A GB 0511019A GB 0511019 A GB0511019 A GB 0511019A GB 0511019 D0 GB0511019 D0 GB 0511019D0
Authority
GB
United Kingdom
Prior art keywords
conjugates
drug fusions
fusions
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0511019A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Domantis Ltd
Original Assignee
Domantis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Domantis Ltd filed Critical Domantis Ltd
Priority to GB0511019A priority Critical patent/GB0511019D0/en
Publication of GB0511019D0 publication Critical patent/GB0511019D0/en
Priority to CN2005800476479A priority patent/CN101128487B/en
Priority to JP2007543909A priority patent/JP5185624B2/en
Priority to KR1020077015211A priority patent/KR20070094909A/en
Priority to NZ555464A priority patent/NZ555464A/en
Priority to RU2007119990/10A priority patent/RU2428431C2/en
Priority to PCT/GB2005/004599 priority patent/WO2006059106A2/en
Priority to AU2005311099A priority patent/AU2005311099B2/en
Priority to CA002589800A priority patent/CA2589800A1/en
Priority to BRPI0518761-3A priority patent/BRPI0518761A2/en
Priority to US11/791,930 priority patent/US20090214534A1/en
Priority to EP20050810713 priority patent/EP1841796A2/en
Priority to EP13163377.8A priority patent/EP2769990A3/en
Priority to MX2007006605A priority patent/MX2007006605A/en
Priority to SG200907919-5A priority patent/SG157423A1/en
Priority to IL183450A priority patent/IL183450A0/en
Priority to NO20072751A priority patent/NO20072751L/en
Priority to MA29951A priority patent/MA29079B1/en
Ceased legal-status Critical Current

Links

GB0511019A 2004-12-02 2005-05-31 Drug fusions and conjugates Ceased GB0511019D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GB0511019A GB0511019D0 (en) 2005-05-31 2005-05-31 Drug fusions and conjugates
SG200907919-5A SG157423A1 (en) 2004-12-02 2005-11-30 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
CA002589800A CA2589800A1 (en) 2004-12-02 2005-11-30 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
US11/791,930 US20090214534A1 (en) 2004-12-02 2005-11-30 Bispecific Domain Antibodies Targeting Serum Albumin And GLP-1 Or PYY
KR1020077015211A KR20070094909A (en) 2004-12-02 2005-11-30 Bispecific domain ant1bodies targeting serum albumin and glp-1 or pyy
NZ555464A NZ555464A (en) 2004-12-02 2005-11-30 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
RU2007119990/10A RU2428431C2 (en) 2004-12-02 2005-11-30 Fused drug constructs and conjugates
PCT/GB2005/004599 WO2006059106A2 (en) 2004-12-02 2005-11-30 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
AU2005311099A AU2005311099B2 (en) 2004-12-02 2005-11-30 Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY
CN2005800476479A CN101128487B (en) 2004-12-02 2005-11-30 Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY
BRPI0518761-3A BRPI0518761A2 (en) 2004-12-02 2005-11-30 drug fusion, drug conjugate, Recombinant Nucleic Acid, Nucleic Acid Construction, Host Cell, Method for Producing a Drug Fusion, Pharmaceutical Composition, Drug, Method of Treatment and / or Prevention of a Condition in a Patient, Delay Method or prevention of disease progression, and a method for decreasing food absorption by a patient
JP2007543909A JP5185624B2 (en) 2004-12-02 2005-11-30 Bispecific antibodies targeting serum albumin and GLP-1 or PYY
EP20050810713 EP1841796A2 (en) 2004-12-02 2005-11-30 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
EP13163377.8A EP2769990A3 (en) 2004-12-02 2005-11-30 Bispecific domain antibodies targeting serum albumin and GLP-1 or PYY
MX2007006605A MX2007006605A (en) 2004-12-02 2005-11-30 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy.
IL183450A IL183450A0 (en) 2004-12-02 2007-05-28 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
NO20072751A NO20072751L (en) 2004-12-02 2007-05-30 Bispecific domain antibodies targeted against serum albumin and GLP-1 or PYY
MA29951A MA29079B1 (en) 2004-12-02 2007-05-30 MERGERS AND MEDICINAL CONJUGATES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0511019A GB0511019D0 (en) 2005-05-31 2005-05-31 Drug fusions and conjugates

Publications (1)

Publication Number Publication Date
GB0511019D0 true GB0511019D0 (en) 2005-07-06

Family

ID=34834862

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0511019A Ceased GB0511019D0 (en) 2004-12-02 2005-05-31 Drug fusions and conjugates

Country Status (1)

Country Link
GB (1) GB0511019D0 (en)

Similar Documents

Publication Publication Date Title
HK1246200A1 (en) Beta-glucuronide drug linker conjugates
IL179633A0 (en) Drug compositions, fusions and conjugates
HK1117410A1 (en) Antibody-drug conjugates and their use
ZA201006763B (en) Drug fusions and conjugates
IL186521A0 (en) Nanoparticle-active ingredient conjugates
EP1781689A4 (en) Conjugates and therapeutic uses thereof
IL185280A0 (en) Tetrahydroindolone and tetrahydroindazolone derivatives
IL180762A (en) Insulin-oligomer conjugates and formulations and uses thereof
PL1877073T3 (en) Non-cytotoxic protein conjugates
IL179077A0 (en) Chemical linkers and conjugates thereof
SI1957073T1 (en) Medicinal drug
EP1718335A4 (en) Drug conjugates
AP2008004533A0 (en) Pharmaceutical combination
EP1876178A4 (en) Cyanopyridine derivative and use thereof as medicine
IL176918A0 (en) Ghrelin-carrier conjugates
GB0516069D0 (en) Pharmaceutical and use thereof
IL187479A0 (en) Antigen conjugates and uses thereof
EP1714648A4 (en) Combination drug
EP1838317A4 (en) Analgesic conjugates
EP2025667A4 (en) 9,10-secopregnane derivative and pharmaceutical
EP1940386A4 (en) Wortmannin conjugates and uses thereof
ZA200804666B (en) Pharmaceutical combination
IL181228A0 (en) Vlp-antigen conjugates and their uses as vaccines
TWI372053B (en) Combination drug
PL1944298T3 (en) Quinazoline derivative and pharmaceutical

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)